Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This trial sest to assess the efficacy of a superior hypogastric plexus block (SHPB) for quality of recovery after a laparoscopic hysterectomy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Nerve block | Experimental | The superior hypogastric plexus block in this group will contain 20 mL of 0.75% ropivacaine hydrochloride. |
|
| Placebo block | Placebo Comparator | The superior hypogastric plexus block in this group will contain 20 mL of 0.9% normal saline. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Superior hypogastric plexus block | Procedure | Prior to the laparoscopic hysterectomy and any additional procedures, the superior hypogastric plexus block will be performed on all the patients. The block will contain 20 mL of 0.75% ropivacaine hydrochloride or 0.9% normal saline. The injection will be performed by tenting the presacral peritoneum, aspirating with a laparoscopic needle-tip syringe to ensure extravascular placement, and injecting the block. |
| Measure | Description | Time Frame |
|---|---|---|
| Quality of recovery | The Quality of recovery (QoR) 15 is a patient-reported outcome questionnaire that measures the quality of recovery after surgery. | Postoperative day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| Postoperative Pain Scores | Pain reported according to a visual rating scale from 0 to 100 points (0= no pain and 100= worst imaginable pain), which details their pain level using Visual Analog Scale (VAS) pain scores from the Brief Pain Inventory (BPI). Pain is reported on a scale of 1 to 100, and a higher score indicates greater pain intensity. | Up to postoperative day 2 |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009407 | Nerve Block |
| ID | Term |
|---|---|
| D000765 | Anesthesia, Conduction |
| D000758 | Anesthesia |
| D000760 | Anesthesia and Analgesia |
| D003714 | Denervation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Postoperative Opioid Use | Postoperative opioid consumption during said time points | Up to postoperative day 2 |
| The Brief Pain Inventory (BPI) | The Brief Pain Inventory (BPI) is a self-administered questionnaire to assess the severity of pain and the impact of pain on the patient's daily functions. | Up to postoperative day 90 |
| The McGill Pain Questionnaire | The McGill Pain Questionnaire can be used to evaluate a person experiencing significant pain. | Up to postoperative day 90 |
| Incidence of Adverse events | Incidence of adverse events related to the plexus block (vascular puncture, hematoma, and local anesthetic systemic toxicity (LAST)) | Intraoperative (During block performance) |
| Length of stay in post-anesthesia care unit (PACU) area | Total time in PACU area | Postoperative day 1 |
| Quality of recovery | The Quality of recovery (QoR) 15 is a patient-reported outcome questionnaire that measures the quality of recovery after surgery. | Up to postoperative day 2 |
| Postoperative nausea and vomiting | number of participants with nausea or vomiting | Up to postoperative day 2 |
| D019635 |
| Neurosurgical Procedures |
| D013514 | Surgical Procedures, Operative |